The prevalence of the @entity594 -induced @entity7138 is ranging from 0.5-83% in the dental literature. The pathomechanism of the @entity594 -induced @entity7138 is not clearly understood. Evaluating the dental history and the course of disease of 34 @entity1 treated and followed up at the Department of Periodontology the following answers were raised: What sort of local and systemic factors are enhancing the recurrence of the @entity8032 and how this can be anticipated in @entity1 on continuous Ca channel blocking medication. Eight out of the 34 @entity1 participating in the clinical trial did not remember the onset of their @entity8032 . 10 cases developed three years and three cases after less then one year of the onset of the drug administrations. 27 out of the 34 cases required gingival surgery and seven showed good clinical improvement after the hygienic phase of the comprehensive periodontal treatment. 70% of the @entity7138 cases presented no clinical sign of recurrence one year after the completion of the active phase of the treatment. A positive correlation was found between the oral hygiene and the recurrence rate of @entity8032 . Oral hygiene seems to play a decisive role in the development of @entity1283 . The present findings and substantial evidences from the dental literature indicate that the @entity1283 can be successfully controlled even under the continuous @entity594 administration by meticulous professional and individual oral hygiene.

[Clinical experience with the treatment of XXXX induced by calcium channel blocking agents].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1283 :: ('MESH:D006332', 'Disease') :: ['gingival enlargement'] @entity594 :: ('MESH:D009543', 'Chemical') :: ['nifedipine'] @entity7138 :: ('MESH:D005885', 'Disease') :: ['gingival hyperplasia'] @entity8032 :: ('MESH:D019214', 'Disease') :: ['gingival overgrowth']
@entity7138 :: (MESH:D005885,Disease) :: ['gingival hyperplasia']
